Fonterra JV to buy lactose business from Dutch partner Royal FrieslandCampina

Fonterra Cooperative Group, the world’s biggest dairy exporter, said its joint venture with Royal FrieslandCampina will acquire the Dutch milk products group’s pharmaceutical lactose business for about $106 million.

Fonterra’s share of the purchase price is $53 million, the cooperative said in a statement today. The DMV-Fonterra Excipients JV will acquire the FrieslandCampina Domo-Pharma unit subject to regulatory approvals in a deal expected by March, it said.

The transaction will add value to Fonterra by creating a larger scale pharmaceutical lactose business, said Andrei Mikhalevsky, managing director for ingredients. The deal would combine the two companies’ R&D capabilities, he said. 

Businesswire.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

FSF - Fonterra completes sale of Mainland Group to Lactalis
GNE - Resignation of Chief Financial Officer
PFI - Property for Industry Limited Launches Bond Offer
March 30th Morning Report
HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update
PFI - Potential Bond Offer by PFI
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report